Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

miR-7 expression in serous ovarian carcinomas.

Swiercz A, Chechlinska M, Kupryjanczyk J, Dansonka-Mieszkowska A, Rembiszewska A, Goryca K, Kulinczak M, Zajdel M, Sromek M, Siwicki JK.

Anticancer Res. 2015 Apr;35(4):2423-9.

PMID:
25862909
2.

Time-dependent supplementation of vitamin E influences leptin expression in the aortic layers of rats fed atherogenic diet.

Krawczynska A, Olczak E, Rembiszewska A, Herman AP, Gromadzka-Ostrowska J.

J Physiol Pharmacol. 2014 Feb;65(1):33-9.

3.

Ovarian small cell carcinoma of hypercalcemic type - evidence of germline origin and SMARCA4 gene inactivation. a pilot study.

Kupryjańczyk J, Dansonka-Mieszkowska A, Moes-Sosnowska J, Plisiecka-Hałasa J, Szafron L, Podgórska A, Rzepecka IK, Konopka B, Budziłowska A, Rembiszewska A, Grajkowska W, Spiewankiewicz B.

Pol J Pathol. 2013 Dec;64(4):238-46.

4.

Cyclooxygenase-2 immunohistochemical expression in serrated polyps of the colon.

Kiedrowski M, Mroz A, Kraszewska E, Rembiszewska A, Felisiak-Golabek A, Kupryjanczyk J, Deptala A, Orlowska J.

Contemp Oncol (Pozn). 2014;18(6):409-13. doi: 10.5114/wo.2014.47907.

5.

p19(INK4d) mRNA and protein expression as new prognostic factors in ovarian cancer patients.

Felisiak-Golabek A, Dansonka-Mieszkowska A, Rzepecka IK, Szafron L, Kwiatkowska E, Konopka B, Podgorska A, Rembiszewska A, Kupryjanczyk J.

Cancer Biol Ther. 2013 Oct 1;14(10):973-81. doi: 10.4161/cbt.25966.

6.

High-fat, cholesterol-rich diet affects leptin expression in the aortic layers.

Krawczynska A, Olczak E, Rembiszewska A, Gromadzka-Ostrowska J.

Exp Biol Med (Maywood). 2013 Jan;238(1):47-56. doi: 10.1258/ebm.2012.012228.

PMID:
23479763
7.

Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients.

Felisiak-Golabek A, Rembiszewska A, Rzepecka IK, Szafron L, Madry R, Murawska M, Napiorkowski T, Sobiczewski P, Osuch B, Kupryjanczyk J; Polish Ovarian Cancer Study Group (POCSG)..

J Ovarian Res. 2011 Nov 10;4(1):20. doi: 10.1186/1757-2215-4-20.

8.

NANOS1 and PUMILIO2 bind microRNA biogenesis factor GEMIN3, within chromatoid body in human germ cells.

Ginter-Matuszewska B, Kusz K, Spik A, Grzeszkowiak D, Rembiszewska A, Kupryjanczyk J, Jaruzelska J.

Histochem Cell Biol. 2011 Sep;136(3):279-87. doi: 10.1007/s00418-011-0842-y.

PMID:
21800163
9.

HAX-1 overexpression, splicing and cellular localization in tumors.

Trebinska A, Rembiszewska A, Ciosek K, Ptaszynski K, Rowinski S, Kupryjanczyk J, Siedlecki JA, Grzybowska EA.

BMC Cancer. 2010 Mar 2;10:76. doi: 10.1186/1471-2407-10-76.

10.

The SNARE-associated component SNAPIN binds PUMILIO2 and NANOS1 proteins in human male germ cells.

Ginter-Matuszewska B, Spik A, Rembiszewska A, Koyias C, Kupryjanczyk J, Jaruzelska J.

Mol Hum Reprod. 2009 Mar;15(3):173-9. doi: 10.1093/molehr/gap004.

11.

PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients.

Kolasa IK, Rembiszewska A, Felisiak A, Ziolkowska-Seta I, Murawska M, Moes J, Timorek A, Dansonka-Mieszkowska A, Kupryjanczyk J.

Cancer Biol Ther. 2009 Jan;8(1):21-6.

PMID:
19029838
12.

TP53, BCL-2 and BAX analysis in 199 ovarian cancer patients treated with taxane-platinum regimens.

Ziółkowska-Seta I, Madry R, Kraszewska E, Szymańska T, Timorek A, Rembiszewska A, Kupryjańczyk J.

Gynecol Oncol. 2009 Jan;112(1):179-84. doi: 10.1016/j.ygyno.2008.09.008.

PMID:
18937971
13.

PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutations.

Kolasa IK, Rembiszewska A, Janiec-Jankowska A, Dansonka-Mieszkowska A, Lewandowska AM, Konopka B, Kupryjańczyk J.

Gynecol Oncol. 2006 Nov;103(2):692-7.

PMID:
16793127
14.

P27(Kip1) and Ki-67 expression analysis in transitional cell carcinoma of the bladder.

Dybowski B, Kupryjańczyk J, Rembiszewska A, Pykało R, Borkowski A.

Urol Res. 2003 Dec;31(6):397-401.

PMID:
14517702
15.

P21WAF1, P27KIP1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens.

Plisiecka-Hałasa J, Karpińska G, Szymańska T, Ziółkowska I, Madry R, Timorek A, Debniak J, Ułańska M, Jedryka M, Chudecka-Głaz A, Klimek M, Rembiszewska A, Kraszewska E, Dybowski B, Markowska J, Emerich J, Płuzańska A, Goluda M, Rzepka-Górska I, Urbański K, Zieliński J, Stelmachów J, Chrabowska M, Kupryjańczyk J.

Ann Oncol. 2003 Jul;14(7):1078-85.

16.

Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen.

Kupryjańczyk J, Szymańska T, Madry R, Timorek A, Stelmachów J, Karpińska G, Rembiszewska A, Ziółkowska I, Kraszewska E, Debniak J, Emerich J, Ułańska M, Płuzańska A, Jedryka M, Goluda M, Chudecka-Głaz A, Rzepka-Górska I, Klimek M, Urbański K, Breborowicz J, Zieliński J, Markowska J.

Br J Cancer. 2003 Mar 24;88(6):848-54.

17.

Nijmegen breakage syndrome gene (NBS1) alterations and its protein (nibrin) expression in human ovarian tumours.

Plisiecka-Hałasa J, Dansonka-Mieszkowska A, Rembiszewska A, Bidziński M, Steffen J, Kupryjańczyk J.

Ann Hum Genet. 2002 Nov;66(Pt 5-6):353-9.

18.

Spontaneous apoptosis in ovarian carcinomas: a positive association with p53 gene mutation is dependent on growth fraction.

Kupryjańczyk J, Dansonka-Mieszkowska A, Szymańska T, Karpińska G, Rembiszewska A, Rusin M, Konopiński R, Kraszewska E, Timorek A, Yandell DW, Stelmachów J.

Br J Cancer. 2000 Feb;82(3):579-83.

19.

[Ultrastructure of the surface epithelium of the ovary and the epithelium lining the inclusion cysts].

Rembiszewska A, Czerwiński W, Wiszniewska M.

Patol Pol. 1986 Jul-Sep;37(3):214-21. Polish. No abstract available.

PMID:
3562082
20.

Steroidogenic activity in surface epithelium of the human ovary.

Rembiszewska A, Brynczak A.

Folia Histochem Cytobiol. 1985;23(3):159-63.

PMID:
3864648
Items per page

Supplemental Content

Loading ...
Support Center